← Open Payments lookup

SARAH DEBOOR: Open Payments

NPI 1780126524 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,347 in 87 payments from 15 companies in 2025. Trend: 2023 $1,468 · 2024 $1,482 · 2025 $2,347

Food & beverage: $2,347
CompanyPaymentsAmount
ABBVIE INC.33$585
Janssen Biotech, Inc.16$335
Gilead Sciences, Inc.3$270
Madrigal Pharmaceuticals5$228
Phathom Pharmaceuticals, Inc.7$179
GENZYME CORPORATION4$173
Aimmune Therapeutics, Inc.4$164
Novo Nordisk Inc1$118
Ipsen Biopharmaceuticals, Inc3$71
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$70

Products named: TREMFYA, RINVOQ, REZDIFFRA, DUPIXENT, VOQUEZNA, SKYRIZI, ZENPEP, Livdelzi.

Industry payments across NV — which companies pay providers there.